Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-05-02
1990-03-20
Robinson, Ellis P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424447, 424448, 424449, A61K 970
Patent
active
049102052
ABSTRACT:
A pharmaceutical composition for the transdermal delivery of loratadine comprising isopropyl myristate and rosemary oil and the method of using such a composition for the treatment of allergic reactions are disclosed.
REFERENCES:
patent: 4560553 (1985-12-01), Zupan
patent: 4659716 (1987-04-01), Villani et al.
Kogan Patricia W.
Sequeira Joel A.
Horne Leon R.
Magatti Anita W.
Maitner John J.
Miller Stephen I.
Robinson Ellis P.
LandOfFree
Transdermal delivery of loratadine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal delivery of loratadine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal delivery of loratadine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-793083